ConductScience.org, home

Paper9844827

The optimization of helper T lymphocyte (HTL) function in vaccine development.

Alexander J and 10 others. Immunol Res, 1998. Cited by 129 papers, by iCite.

Cite this record

ConductScience Library. The optimization of helper T lymphocyte (HTL) function in vaccine development. Papers, record 9844827. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9844827

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The optimization of helper T lymphocyte (HTL) function in vaccine development.
PubMed
Journal
Immunol Res
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
129
iCite
Relative citation ratio, by iCite
2.73
iCite
Revised in PubMed
2026-10-11
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alexander JJ
2Fikes JJ
3Hoffman SS
4Franke EE
5Sacci JJ
6Appella EE
7Chisari FVF V
8Guidotti LGL G
9Chesnut RWR W
10Livingston BB
11Sette AA

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EpitopesMajor topic
HLA-DR AntigensMajor topic
T-Lymphocytes, Helper-InducerMajor topic
Vaccines, SyntheticMajor topic
Animals
Antigens, Protozoan
B-Lymphocytes
Hepatitis B Vaccines
Humans
Immunity, Cellular
Malaria
Mice
Plasmodium
Protozoan Proteins
T-Lymphocytes, Cytotoxic

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
N01-AI-45241NIAID NIH HHSUnited StatesN01AI045241PubMed and NIHNIH RePORTER
R01 AI 2001NIAID NIH HHSUnited StatesPubMedPubMed
R37 CA 40489NCI NIH HHSUnited StatesR37CA040489PubMed and NIHNIH RePORTER

Download CSV of grants

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18093457The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.J Immunol1993https://conductscience.org/library/papers/8093457PubMed
22230128Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.J Immunol1990https://conductscience.org/library/papers/2230128PubMed
39252123Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles.Immunity1997https://conductscience.org/library/papers/9252123PubMed
410072562Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.J Immunol1999https://conductscience.org/library/papers/10072562PubMed
59029118Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells.J Immunol1997https://conductscience.org/library/papers/9029118PubMed
67836921Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II.J Exp Med1995https://conductscience.org/library/papers/7836921PubMed
71401902DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles.J Immunol1992https://conductscience.org/library/papers/1401902PubMed
82463305Delineation of several DR-restricted tetanus toxin T cell epitopes.J Immunol1989https://conductscience.org/library/papers/2463305PubMed
97814635Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.J Clin Invest1995https://conductscience.org/library/papers/7814635PubMed
101717570On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs.J Immunol1991https://conductscience.org/library/papers/1717570PubMed
112717617Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2717617PubMed
121684784Selective activation of Th1- and Th2-like cells in vivo--response to human collagen IV.Immunol Rev1991https://conductscience.org/library/papers/1684784PubMed
131711074Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.J Immunol1991https://conductscience.org/library/papers/1711074PubMed
142094592Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites.Bull World Health Organ1990https://conductscience.org/library/papers/2094592PubMed
158476576T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages.Annu Rev Immunol1993https://conductscience.org/library/papers/8476576PubMed
168316295Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.Nature1993https://conductscience.org/library/papers/8316295PubMed
178145819Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.Nature1994https://conductscience.org/library/papers/8145819PubMed
182963699Structural model of HLA-DR1 restricted T cell antigen recognition.Cell1988https://conductscience.org/library/papers/2963699PubMed
191967273CD4+ T cell-mediated killing of MHC class II-positive antigen-presenting cells. I. Characterization of target cell recognition by in vivo or in vitro activated CD4+ killer T cells.J Immunol1990https://conductscience.org/library/papers/1967273PubMed
202481588Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.Eur J Immunol1989https://conductscience.org/library/papers/2481588PubMed

See all 102 referencesDownload CSV of references

Cited by67

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.

PMIDTitleJournalYearIn PapersSource
42984541Rational design of a multi-epitope vaccine targeting the stress-associated proteins for Mycoplasma fermentans via immunoinformatics.Front Bioinform2026https://conductscience.org/library/papers/42984541PubMed
42797492Pangenome-Guided In Silico Design and Structural Evaluation of a Multi-Epitope Vaccine Candidate Against Streptococcus suis.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42797492PubMed
42045246Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21.NPJ Vaccines2026https://conductscience.org/library/papers/42045246PubMed
41901794Multi-Epitope DNA-Based Feline Immunodeficiency Virus Vaccine Construct Designed by Immunoinformatic and Machine Learning Tools as a Surrogate Model for HIV Vaccine Development.Pathogens2026https://conductscience.org/library/papers/41901794PubMed
41752180A DNA Vaccine Incorporating the MHC Class I Trafficking Domain and PADRE Epitope Enhances Antitumor Immunity in a Murine Pancreatic Cancer Model.Int J Mol Sci2026https://conductscience.org/library/papers/41752180PubMed
41654930Computational design of a novel multi-epitope vaccine candidate against group A rotavirus.Virol J2026https://conductscience.org/library/papers/41654930PubMed
41459947Analysis of MHC class II-bound CyHV-2 peptides in Carassius gibelio using mass spectrometry.J Virol2026https://conductscience.org/library/papers/41459947PubMed
41304878Computational Development of Multi-Epitope Reovirus Vaccine with Potent Predicted Binding to TLR2 and TLR4.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41304878PubMed
41154730Consensus-Guided Construction of H5N1-Specific and Universal Influenza a Multiepitope Vaccines.Biology (Basel)2025https://conductscience.org/library/papers/41154730PubMed
41011130In Silico Development of a Chimeric Multi-Epitope Vaccine Targeting Helcococcus kunzii: Coupling Subtractive Proteomics and Reverse Vaccinology for Vaccine Target Discovery.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41011130PubMed
40964283Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21.bioRxiv2025https://conductscience.org/library/papers/40964283PubMed
40650846Design a multi-epitope vaccine candidate against Acinetobacter baumannii using advanced computational methods.AMB Express2025https://conductscience.org/library/papers/40650846PubMed
40641804Deep learning in next-generation vaccine development for infectious diseases.Mol Ther Nucleic Acids2025https://conductscience.org/library/papers/40641804PubMed
40636082Comprehensive immunoinformatics guided design and in silico assessment of a multi-epitope vaccine to elicit immunity against Mayaro virus.In Silico Pharmacol2025https://conductscience.org/library/papers/40636082PubMed
40583904A robust comprehensive immunoinformatics approach for designing a potential multi-epitope based vaccine against a reiterated monkeypox virus.Biochem Biophys Rep2025https://conductscience.org/library/papers/40583904PubMed
40491911Studies on nanoprotein vaccine alleviating symptoms of mice allergic to rFel d 1.Front Immunol2025https://conductscience.org/library/papers/40491911PubMed
40431317In Silico Design, Optimization, and Evaluation of a Multi-Epitope Vaccine Targeting the Clostridium perfringens Collagen Adhesin Protein.Microorganisms2025https://conductscience.org/library/papers/40431317PubMed
40325041Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigens.NPJ Vaccines2025https://conductscience.org/library/papers/40325041PubMed
40297578Subtractive proteomics and reverse-vaccinology approaches for novel drug targets and designing a chimeric vaccine against Ruminococcus gnavus strain RJX1120.Front Immunol2025https://conductscience.org/library/papers/40297578PubMed
40291442Targeting immunogenic proteins of Zika virus for the prediction of immunoinformatics-driven circular mRNA vaccine model.In Silico Pharmacol2025https://conductscience.org/library/papers/40291442PubMed

See all 67 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9844827

GET https://conductscience.org/api/papers/v1/9844827/references?page=2